LIPIGON CEO AND CO-FOUNDER STEFAN K NILSSON HAS BEEN ELECTED COMMITTEE MEMBER OF PRESTIGOUS EUROPEAN LIPOPROTEIN CLUB
The European Lipoprotein Club (ELC) is the oldest and most active European meeting in the field of lipids.
LIPIGON PHARMACEUTICALS ENTERS INTO TARGET VALIDATION RESEARCH AGREEMENT WITH GERMAN ANTISENSE COMPANY SECARNA PHARMACEUTICALS
Lipigon Pharmaceuticals (“Lipigon”) announced today that it has entered into a Target Validation Research Agreement with Munich-based antisense therapeutics company Secarna Pharmaceuticals (“Secarna”).
LIPIGON HAS BEEN NOMINATED AS UNIVERSITY SPIN-OUT OF THE YEAR
Lipigon is nominated as this year’s spin-out company at UmeåGalan2017.
LIPIGON PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF A NEW CHAIRMAN OF THE BOARD
Effective immediately Lipigon is announcing Dr. Gisela Sitbon as new Chairman of the Board.